Nesland JM - Search Results

1

B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer.

Ingebrigtsen VA, Boye K, Tekle C, Nesland JM, Flatmark K, Fodstad O. Ingebrigtsen VA, et al. Among authors: nesland jm. Int J Cancer. 2012 Dec 1;131(11):2528-36. doi: 10.1002/ijc.27566. Epub 2012 Apr 24. Int J Cancer. 2012. PMID: 22473715

2

Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer.

Flatmark K, Pedersen KB, Nesland JM, Rasmussen H, Aamodt G, Mikalsen SO, Bjørnland K, Fodstad Ø, Maelandsmo GM. Flatmark K, et al. Among authors: nesland jm. J Pathol. 2003 Aug;200(5):589-95. doi: 10.1002/path.1381. J Pathol. 2003. PMID: 12898594

3

Nuclear S100A4 is a novel prognostic marker in colorectal cancer.

Boye K, Nesland JM, Sandstad B, Mælandsmo GM, Flatmark K. Boye K, et al. Among authors: nesland jm. Eur J Cancer. 2010 Nov;46(16):2919-25. doi: 10.1016/j.ejca.2010.07.013. Epub 2010 Aug 16. Eur J Cancer. 2010. PMID: 20719498

4

B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome.

Ingebrigtsen VA, Boye K, Nesland JM, Nesbakken A, Flatmark K, Fodstad Ø. Ingebrigtsen VA, et al. Among authors: nesland jm. BMC Cancer. 2014 Aug 20;14:602. doi: 10.1186/1471-2407-14-602. BMC Cancer. 2014. PMID: 25139714 Free PMC article.

5

Expression and clinical significance of Wee1 in colorectal cancer.

Egeland EV, Flatmark K, Nesland JM, Flørenes VA, Mælandsmo GM, Boye K. Egeland EV, et al. Among authors: nesland jm. Tumour Biol. 2016 Sep;37(9):12133-12140. doi: 10.1007/s13277-016-5081-3. Epub 2016 May 24. Tumour Biol. 2016. PMID: 27220319

6

Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.

Boye K, Jacob H, Frikstad KA, Nesland JM, Maelandsmo GM, Dahl O, Nesbakken A, Flatmark K. Boye K, et al. Among authors: nesland jm. Cancer Med. 2016 Aug;5(8):1840-9. doi: 10.1002/cam4.766. Epub 2016 Jun 8. Cancer Med. 2016. PMID: 27273130 Free PMC article. Clinical Trial.

7

High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targeting.

Haugen MH, Boye K, Nesland JM, Pettersen SJ, Egeland EV, Tamhane T, Brix K, Maelandsmo GM, Flatmark K. Haugen MH, et al. Among authors: nesland jm. Eur J Cancer. 2015 Jan;51(1):9-17. doi: 10.1016/j.ejca.2014.10.020. Epub 2014 Nov 11. Eur J Cancer. 2015. PMID: 25466510

8

Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.

Maelandsmo GM, Holm R, Nesland JM, Fodstad Ø, Flørenes VA. Maelandsmo GM, et al. Among authors: nesland jm. Clin Cancer Res. 2003 Aug 15;9(9):3383-8. Clin Cancer Res. 2003. PMID: 12960126

9

Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma.

Andersen K, Nesland JM, Holm R, Flørenes VA, Fodstad Ø, Maelandsmo GM. Andersen K, et al. Among authors: nesland jm. Mod Pathol. 2004 Aug;17(8):990-7. doi: 10.1038/modpathol.3800151. Mod Pathol. 2004. PMID: 15133476 Free article.

10

Antitumour activity of oral E7080, a novel inhibitor of multiple tyrosine kinases, in human sarcoma xenografts.

Bruheim S, Kristian A, Uenaka T, Suo Z, Tsuruoka A, Nesland JM, Fodstad Ø. Bruheim S, et al. Among authors: nesland jm. Int J Cancer. 2011 Aug 1;129(3):742-50. doi: 10.1002/ijc.25922. Epub 2011 Mar 25. Int J Cancer. 2011. PMID: 21225632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

546 results

Search Page

Filters